Go to Sygnis Pharma AG Homepage
deutsch
english
search
Print
Sitemap
Contact
Home
Company
CNS Program
Investor Relations
News and Media
Contact
Indications
The SYGNIS Approach
Product Development
Products
AX200
AX201
SY300
Clinical Studies
Publications
Stockquote
Products
You are here :
SYGNIS Pharma AG
>
The CNS program
>
Product Development
> Products
Imprint
Disclaimer
© 2012 SYGNIS AG
